Alnylam Pharmaceuticals 10Q 2020 Q1 Quarterly report | ALNY Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: abroad, accessibility, accurately, adolescent, advertising, advice, afflicted, AIA, Aid, aim, aimed, angiotensin, antitrypsin, Argentina, arguing, Asia, biosimilar, Blackstone, blog, bribery, buildup, caption, CCPA, chain, code, comparison, concept, confidence, confident, constantly, corrupt, Council, CTA, culture, cure, cut, cyber, deal, dealing, debarment, debilitating, declared, dedicate, deep, depletion, detect, deter, digital, divorce, domestic, duration, economy, engine, EP, epidemic, ERISA, erosion, exaggerate, examining, exhaustive, experimental, FCPA, felt, fighting, fluidity, GIVLAARI, glycolate, great, GSO, harbor, home, incentive, indirect, insider, internet, intraperiod, Israel, Italy, judicial, Korea, lab, laundering, leverage, leveraging, lien, likelihood, LP, met, misconduct, missed, monetization, multinational, nedosiran, nonessential, nonpayment, OECD, officially, onboard, online, onsite, opt, orphan, outbreak, overhead, overturned, oxidase, palliation, pandemic, PATRIOT, payroll, peak, perspective, PH, physiological, posed, post, postpone, precautionary, precision, prejudice, prepaid, procure, protease, rapid, recession, referenced, regular, reimportation, rejected, reliable, remotely, repay, reply, resale, retroactive, rolling, routine, Russia, sequester, serine, shift, shifting, simplify, slower, smaller, sought, South, Spain, spread, staffing, STAr, statutory, stemming, stimulate, stream, subordinated, Sunshine, surfaced, susceptibility, susceptible, Sweden, switch, terminology, threatened, town, tranche, transmembrane, Trust, Turkey, underway, undue, unmanaged, untitled, USA, virtual, Wilmington, withdrew, yielded

Removed: acid, activation, adjustment, al, aminolevulinic, amyloid, anniversary, arisen, ascribed, Bank, bankruptcy, BBA, block, borrow, borrower, bought, bound, call, callable, carefully, caution, close, collateralized, combine, commencing, comparing, computed, concentrated, confirming, constructing, corridor, counterparty, crucial, culminated, deduction, defer, determinable, directing, direction, disclaim, discussed, earliest, Eastern, ePrivacy, ESC, exacerbate, expedient, expensed, expired, expressly, extraordinary, Fargo, feasibility, feature, fixed, foregoing, forward, fundamentally, guaranteed, guarantor, harmful, hereof, implicit, importance, incremental, ineffective, injunctive, inseverable, interact, interferon, investor, issuance, judge, Kendall, leased, leasing, lender, lessor, LIBOR, line, literature, location, Main, mandate, marginal, maturity, McSwiggen, measurement, mentioned, middle, Middlesex, minimum, Ministry, modified, monthly, mutant, networking, Northern, oral, outlined, overview, package, permitted, Pharma, pharmacological, PMDA, practical, premium, proposal, propose, provisional, published, purely, refinancing, reinitiation, relaxing, renew, rent, repaid, repeal, rest, restraining, retrospectively, ruled, ruling, SAKIGAKE, satisfying, shortening, skepticism, spend, spent, standstill, staying, Street, suit, Switzerland, synthase, taxable, taxed, TCJA, technique, Tekmira, terminating, undergo, understand, undeveloped, validation, viability, vote, web, West, wrong


Dated: May 6, 2020			/s/ John M. Maraganore
			John M. Maraganore, Ph.D. Chief Executive Officer

Alnylam Pharmaceuticals (ALNY) 10-Q2020 Q1 Quarterly report

Content analysis